bioRxiv Science⌕ Search

Biology subjects

Negredo, P.

Publications and source records attributed to Negredo, P..

2 recordsLinked to original sources

Long-term Nrf2-driven microglial repopulation mitigates microgliosis, neuronal loss and cognitive deficits in tauopathy

A prominent pathological feature of tauopathies, including Alzheimers disease, is a chronic microglial reactivity, which contributes to neuroinflammation and disease progression. Microglia, the innate immune cells of the brain, can be pharmacologically eliminated by inhibiting the colony stimulating factor 1 receptor (e.g. with PLX5622), which is essential for their survival and proliferation. Upon inhibitor withdrawal, microglia rapidly repopulate, replenishing the central nervous system niche with naive cells. In recent years, microglia repopulation strategies have gained great interest as a means to reprogram dysfunctional microglia, while avoiding the detrimental effects of prolonged immune depletion. Despite promising short-term results, the long-term efficacy and pharmacological modulation of repopulated microglial remain poorly understood. Here, we investigate whether repopulated microglia after PLX5622 treatment sustains their beneficial effects over time in an AAV-hTauP301L induced model. Additionally, we assessed whether activating the cytoprotective nuclear factor erythroid 2 p45-related factor 2 (Nrf2) during microglial repopulation enhanced and prolonged the therapeutic outcomes. While microglial repopulation alone failed to maintain its neuroprotection in the long-term, when combined with an Nrf2 inducer, it improved cognitive deficits, reverted hippocampal neuronal loss and restored microglial phenotypes and mitochondrial energetics homeostasis, in our tauopathy-induced model. These results highlight the importance of shaping the fate of self-renewed microglia and propose Nrf2-mediated microglia repopulation as a potential pharmacological strategy for the treatment of tauopathies. HIGHLIGHTSO_LINrf2 inducer ND523 boosts long-term repopulated microglia function in tauopathy. C_LIO_LIND523-mediated microglial repopulation mitigates tau-induced cognitive decline. C_LIO_LIND523-driven microglial repopulation reduces neuronal loss without altering p-tau. C_LIO_LIND523-microglial repopulation rescues microglial morphology and reduces reactivity. C_LIO_LIND523-mediated repopulation prevents mitochondrial energetics dysfunctions. C_LI

neuroscience↗

Neuronal NOX4 knockdown alleviates pathological tau-related alterations in a humanized mouse model of tauopathy

Approximately 44 million people worldwide live with Alzheimers disease (AD) or a related form of dementia. Aggregates of the microtubule-associated protein tau are a common marker of these neurodegenerative diseases collectively termed as tauopathies. However, all therapeutic attempts based on tau have failed, suggesting that tau may only indicate a higher-level causal mechanism. For example, increasing levels of reactive oxygen species (ROS) may trigger protein aggregation or modulate protein degradation. Here we show that type 4 NADPH oxidase (NOX), the most abundant isoform of the only dedicated reactive oxygen producing enzyme family, is upregulated in dementia and AD patients and in a humanized mouse model of tauopathy. Both global knockout and neuronal knockdown of the Nox4 gene in mice, diminished the accumulation of pathological tau and positively modified established tauopathy by a mechanism that implicates modulation of the autophagy-lysosomal pathway (ALP). Moreover, neuronal-targeted NOX4 knockdown was sufficient to reduce neurotoxicity and prevented cognitive decline, suggesting a direct and causal role for neuronal NOX4. Thus, NOX4 is a previously unrecognized causal, mechanism-based target in tauopathies and blood-brain barrier permeable specific NOX4 inhibitors could have therapeutic potential even in established disease. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=83 SRC="FIGDIR/small/338954v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@1dac496org.highwire.dtl.DTLVardef@1a07dd5org.highwire.dtl.DTLVardef@1a5653aorg.highwire.dtl.DTLVardef@198f3e4_HPS_FORMAT_FIGEXP M_FIG C_FIG

neuroscience↗